stockportfolio.pro
Stocks / HAE vs WAY
HAE vs WAY
Haemonetics Corporation and Waystar Holding Corp. side by side — fundamentals from SEC filings, refreshed nightly. Sector: Healthcare.
| Haemonetics Corporation (HAE) | Waystar Holding Corp. (WAY) | |
|---|---|---|
| Market cap | $3.6B | $3.6B |
| Revenue (latest FY) | $1.33B | $1.10B |
| Net income (latest FY) | $97.31M | $112.09M |
| Revenue growth (5y CAGR) | 8.9% | 16.0% |
| Net margin | 7.3% | 10.2% |
| Return on equity | 12.2% | 2.9% |
| P/E ratio | 38.4 | 28.0 |
| Dividend yield | — | — |
| Profitable years (of last 10) | 9 | 1 |
| Positive free cash flow | Yes | Yes |
Compare them properly — statement by statement
Open either company interactively: 19 years of income statement, balance sheet and cash flow, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open HAE — free Open WAY — freeFrequently asked questions
Which is bigger, HAE or WAY?
Waystar Holding Corp. is larger by market capitalization — $3.6B versus $3.6B.
Which grows faster, HAE or WAY?
Over the last five fiscal years, Waystar Holding Corp. grew revenue faster — 16.0%/yr versus 8.9%/yr, computed from SEC-filed statements.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.